Ascendis Pharma A/S (ASND)

246.44 +4.35 (+1.80%) USD  |  NASDAQ  |  Mar 03, 14:25
More

Ascendis Pharma Extraordinary Items, Income Statement (Quarterly)

Extraordinary Items, Income Statement (Quarterly) Chart

View Extraordinary Items, Income Statement (Quarterly) for ASND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Extraordinary Items, Income Statement (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Extraordinary Items, Income Statement (Quarterly) Range, Past 5 Years

View Extraordinary Items, Income Statement (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Extraordinary Items, Income Statement (Quarterly) Benchmarks

View Extraordinary Items, Income Statement (Quarterly) Benchmarks
Start Trial
Novo Nordisk A/S Upgrade
Evaxion AS Upgrade
DBV Technologies SA Upgrade
Cellectis SA Upgrade
Biodexa Pharmaceuticals Plc --